Robert James Wills
CIK 1634189 · Executive Chairman · last filed 2026-01-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$215.8K
Companies
5
Total Filings
48
Lifetime Open-Market Net
$610.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACOG | Director | 22,241 | $5.99 | $133.2K | $127.3K | 3 | 2026-01-16 |
| MIST | Director | 65,000 | $1.27 | $82.5K | $74.0K | 8 | 2025-07-15 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 10,000 | $0.53 | $5.3K | $77.4K | 11 | 2024-06-24 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | 0 | $32.48 | $0 | $95.1K | 16 | 2024-03-22 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Executive Chairman | 137,344 | — | — | $236.4K | 10 | 2018-06-26 |
Recent Filings · Page 4 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-03 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-02 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | +5,000 | $34.2K | EDGAR |
| 2017-06-30 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-01 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-17 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +123,456 | $100.0K | EDGAR |
| 2016-09-09 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | +25,000 | $60.9K | EDGAR |
| 2016-06-30 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.